When taken orally, it primarily interacts with the gut lining, which may be helpful in models of: Ulcer healing ( Stark et al., 2017 ) Inflammatory bowel conditions ( Sikiric et al., 2015 ) Intestinal barrier protection ( Stark et al., 2017 ) However, oral peptides are subject to breakdown by stomach acid and digestive enzymes, which can limit their absorption into the bloodstream ( Sikiric et al., 2015 )
Modifier Issues If multiple injections are given on the same day, modifiers may be required
Gastrointestinal & Mucosal Integrity BPC-157 has also been studied for its influence on gut and mucosal tissue
What is the FDA actually discussing
In the CY 2024 OPPS/ASC final rule with comment period, we stated that for the Excessive Radiation eCQM, HOPDs may incur costs associated with implementing and maintaining program requirements, such as maintaining measure specifications in hospitals' electronic health record (EHR) systems (88 FR 82167)